IP Library Granted Patent US 8,227,561
Granted Patent B1
US 8,227,561 · App. 13/318,098 · Granted Jul 24, 2012

Bisphenol-A replacement materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,227,561
App. No.
13/318,098
Granted
Jul 24, 2012
Kind
B1
Abstract

Polymers may include a plurality of tetradecahydroanthracene moieties. Such polymers may be used to make food or beverage containers or medical devices. Food or beverage containers or medical devices may be coated with polymers including a plurality of tetradecahydroanthracene moieties.

Claims (36)

1. A polymer comprising at least one repeating unit, wherein the repeating unit comprises a tetradecahydroanthracene moiety represented by Formula I:

wherein:

R 1 -R 4 and R 5 -R 10 are hydrogen and R 9 -R 10 are oxo groups; and

the tetradecahydroanthracene moiety is part of to the polymer backbone through the oxo groups.

2. The polymer of claim 1 , wherein the polymer comprises an epoxy, a polyol, an alkyd, a polycarbonate, a polyester, or a polyurethane.

3. The polymer of claim 1 , wherein the polymer comprises a plurality of tetradecahydroanthracene moieties each represented by Formula II:

4. The polymer of claim 1 , wherein the polymer comprises a plurality of tetradecahydroanthracene moieties represented by Formula VI:

5. The polymer of claim 1 represented by Formula III:

wherein n is an integer from 1 to 1,000,000.

6. The polymer of claim 1 , wherein the polymer comprises a cross-linked epoxy.

7. The polymer of claim 1 , wherein the polymer comprises an epoxy which is cross-linked by an amine, a diamine, a triamine, a tetraamine, an alcohol, a diol, a triol, or a tetraol.

8. The polymer of claim 1 is represented by Formula IV:

wherein n is an integer from 1 to 1,000,000.

9. The polymer of claim 1 , wherein the polymer is an alkyd comprising an esterified polyol backbone comprising a plurality of tetradecahydroanthracene moieties; and a plurality of fatty acid side chains attached to the esterified polyol backbone through ester linkages.

10. The polymer of claim 1 represented by Formula V:

wherein R 11 is independently at each occurrence a fatty acid selected from the group consisting of lauric acid, stearic acid, palmitic acid, oleic acid, linoleic acid, linolenic acid, ricinolenic acid, eleostearic acid, eicosapentaenoic acid, docosahexaenoic acid, stearidonic acid, eicosatrienoic acid, eicosatetraenoic acid, docosapentaenoic acid, clupanodonic acid, tetracosapentaenoic acid, and tetracosahexaenoic acid; and

wherein n is an integer from 1 to 1,000,000.

11. The polymer of claim 1 , wherein the polymer comprises a plurality of tetradecahydroanthracene moieties represented by Formula VII:

12. The polymer of claim 1 , wherein the polymer is a polyester comprising a plurality of tetradecahydroanthracene moieties represented by Formula VIII:

wherein R 12 is alkylene, cycloalkylene, or arylene.

13. The polymer of claim 1 , wherein the polymer is a polyurethane which is cross-linked by an diisocyanate agent selected from the group consisting of methylene-bis(4-cyclohexylisocyanate), 2,2-propylene-bis(4-cyclohexylisocyanate), isophorone diisocyanate, hexamethylene diisocyanate, hexamethylene diisocyanate dimer, hexamethylene diisocyanate trimer, polyisocyanates, toluene diisocyanate, methylene-bis(4-phenylisocyanate), benzene diisocyanate, and cyclohexane diisocyanate.

14. The polymer of claim 1 , wherein the polymer is a polyurethane comprising a plurality of tetradecahydroanthracene moieties represented by Formula (IX):

wherein R 13 is selected from the group consisting of alkylene, cycloalkylene, or arylene.

15. The polymer of claim 1 , wherein the polymer is a random copolymer, a block copolymer, or a graft copolymer.

16. The polymer of claim 1 , wherein the polymer further comprises at least one graft side chain, wherein the graft side chain comprises a polyacrylate, a polyolefin, or a copolymer thereof.

17. The polymer of claim 16 , wherein the polyacrylate comprises acrylate monomers selected from the group consisting of acrylic acid, methacrylic acid, acrylic acid esters, and methacrylic acid esters.

18. The polymer of claim 16 , wherein the polyolefin comprises vinyl monomers selected from the group consisting of styrene, α-methylstyrene, butadiene, ethylene, propylene, vinyl chloride, vinylidene chloride, vinyl acetate, vinyl ether, vinyl fluoride, and vinylidene fluoride.

19. The polymer of claim 1 , wherein the polymer comprises a plurality of tetradecahydroanthracene moieties represented by Formula X:

wherein R 14 is independently at each occurrence selected from the group consisting of hydrogen, a polyacrylate, a polyolefin, and a copolymer of an acrylate monomer and a vinyl monomer.

20. A method of preparing a first polymer comprising a plurality of tetradecahydroanthracene moieties of claim 1 , the method comprising:

hydrogenating a second polymer comprising a plurality of anthracene moieties.

21. The method of claim 20 , wherein the tetradecahydroanthracene moieties are represented by Formula II:

22. The method of claim 20 , wherein the anthracene moieties are represented by Formula XI:

23. The method of claim 20 , wherein the first polymer is represented by Formula III:

wherein n is an integer from 1 to 1,000,000.

24. An article comprising the polymer of claim 1 , wherein the article is a food container, a beverage container, or a medical device.

Assignments (1)
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →